Get the Stockscreener App
586.80
2.37%
14.06
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $586.80, with a volume of 1.35M.
It is up +2.37% in the last 24 hours and up +5.08% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$572.74
Open:
$573
24h Volume:
1.35M
Relative Volume:
0.69
Market Cap:
$220.45B
Revenue:
$43.74B
Net Income/Loss:
$6.58B
P/E Ratio:
33.90
EPS:
17.3072
Net Cash Flow:
$6.11B
1W Performance:
+1.32%
1M Performance:
+5.08%
6M Performance:
+47.22%
1Y Performance:
+13.61%
1-Day Range:
$569.55
$589.85
1-Week Range:
$556.46
$589.85
52-Week Range:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
586.77 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.54 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
730.25 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
151.37 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.81 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report? - Yahoo Finance
Oncology Biomarker Market Accelerates Toward USD 113.5 Billion by 2034 - GlobeNewswire Inc.
Genomic Biomarker Market By Top Companies Illumina,Thermo - openPR.com
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer - BioSpace
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth - The Globe and Mail
TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner - TradingView
Thermo Fisher Expands U.S. Cell & Gene Therapy Network with New Advanced Therapies Center in Philadelphia - Voice Of HealthCare
Can Thermo Fisher Scientific Inc. stock sustain institutional interestMarket Risk Analysis & Short-Term High Return Ideas - newser.com
The Bull Case For Thermo Fisher Scientific (TMO) Could Change Following EXENT System Clearance and New Philly Center Opening – Learn Why - Yahoo Finance
Will Thermo Fisher Scientific Inc. (TN8) stock sustain bullish trend into 2025Market Trend Report & Consistent Income Trade Ideas - newser.com
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock behaves in tightening cyclesTrade Exit Summary & Safe Entry Zone Identification - newser.com
Institutions Love These 3 Companies, Should You As Well? - Finviz
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two - PharmTech.com
Thermo Fisher unveils Advanced Therapies Collaboration Centre in US - BioSpectrum Asia
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing* - bastillepost.com
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing - Morningstar
Why Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock signals breakout potential2025 Analyst Calls & AI Driven Stock Reports - newser.com
Is Thermo Fisher Scientific Inc. (TN8) stock expanding market penetration2025 Market Outlook & Safe Capital Growth Tips - newser.com
How robust is Thermo Fisher Scientific Inc stock financial positionBreakout Watch & Advanced Swing Trade Entry Plans - newser.com
Is Thermo Fisher Scientific Inc stock supported by strong fundamentalsJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development - BioSpace
Will Thermo Fisher Scientific Inc. (TN8) stock outperform global peersJuly 2025 Action & Long-Term Growth Stock Strategies - newser.com
Will Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock beat value stocksQuarterly Earnings Report & High Accuracy Trade Alerts - newser.com
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs - citybiz
Is Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock attractive for growth funds2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
Why Thermo Fisher chose Philly for its new East Coast collaboration center for biotech startups - The Business Journals
Thermo Fisher targets early-stage CGT bottlenecks with new Philadelphia hub - rdworldonline.com
Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Philadelphia - Contract Pharma
These 3 Stocks Are Using Buybacks to Signal Market Confidence - Finviz
Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga
Thermo Fisher Scientific Digital Transformation Strategy Analysis Report 2025: Accelerators, Incubators, and Other Innovation ProgramsResearchAndMarkets.com - Bluefield Daily Telegraph
Moody’s upgrades Thermo Fisher Scientific to A2, outlook stable - Investing.com
Thermo Fisher Scientific Inc. (NYSE:TMO) Is a Favorite Amongst Institutional Investors Who Own 89% - 富途牛牛
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder - The AI Journal
Thermo Fisher Scientific launches CorEvitas clinical registry in myasthenia gravis - PharmaLive
Will Thermo Fisher Scientific Inc. (TN8) stock split increase liquidityMarket Movement Recap & Risk Controlled Stock Alerts - newser.com
A Closer Look at Thermo Fisher Scientific's (TMO) Valuation After Recent Share Price Strength - simplywall.st
Is Thermo Fisher Scientific Inc. (TN8) stock considered safe havenJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com
Can Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock expand revenue streamsTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Thermo Fisher Scientific Inc. (TN8) stock supported by strong fundamentalsWeekly Earnings Recap & Real-Time Stock Price Movement Reports - newser.com
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock gains from tech spendingJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
If You Invested $1000 in Thermo Fisher Scientific 10 Years Ago, This Is How Much You'd Have Now - sharewise.com
Is Thermo Fisher Scientific Inc stock in buy zone after pullbackDividend Hike & Daily Chart Pattern Signal Reports - newser.com
Insider Sell: Lisa Britt Sells Shares of Thermo Fisher Scientifi - GuruFocus
Will Thermo Fisher Scientific Inc stock outperform benchmarks2025 Top Decliners & Safe Swing Trade Setups - newser.com
Rx Rundown: Metagenomi, Chiesi, Thermo Fisher Scientific and more - Medical Marketing and Media
Thermo Fisher Scientific Insider Sold Shares Worth $2,756,920, According to a Recent SEC Filing - MarketScreener
Will Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock hit analyst forecastsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Why Thermo Fisher Scientific Inc. (TN8) stock remains top ratedTrade Signal Summary & Risk Controlled Stock Alerts - Fundação Cultural do Pará
The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific - Nasdaq
Kimberly-Clark, Thermo Fisher Scientific, Berkshire Hathaway And An Industrial Stock On CNBC's 'Final Trades' - Benzinga
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):